These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 16301602)

  • 1. Small interfering RNAs containing full 2'-O-methylribonucleotide-modified sense strands display Argonaute2/eIF2C2-dependent activity.
    Kraynack BA; Baker BF
    RNA; 2006 Jan; 12(1):163-76. PubMed ID: 16301602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference tolerates 2'-fluoro modifications at the Argonaute2 cleavage site.
    Muhonen P; Tennilä T; Azhayeva E; Parthasarathy RN; Janckila AJ; Väänänen HK; Azhayev A; Laitala-Leinonen T
    Chem Biodivers; 2007 May; 4(5):858-73. PubMed ID: 17511001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5' binding MID domain of human Argonaute2 tolerates chemically modified nucleotide analogues.
    Deleavey GF; Frank F; Hassler M; Wisnovsky S; Nagar B; Damha MJ
    Nucleic Acid Ther; 2013 Feb; 23(1):81-7. PubMed ID: 23289589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing.
    Harborth J; Elbashir SM; Vandenburgh K; Manninga H; Scaringe SA; Weber K; Tuschl T
    Antisense Nucleic Acid Drug Dev; 2003 Apr; 13(2):83-105. PubMed ID: 12804036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzyme.
    Li F; Pallan PS; Maier MA; Rajeev KG; Mathieu SL; Kreutz C; Fan Y; Sanghvi J; Micura R; Rozners E; Manoharan M; Egli M
    Nucleic Acids Res; 2007; 35(19):6424-38. PubMed ID: 17881374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi.
    Martinez J; Patkaniowska A; Urlaub H; Lührmann R; Tuschl T
    Cell; 2002 Sep; 110(5):563-74. PubMed ID: 12230974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High potency silencing by single-stranded boranophosphate siRNA.
    Hall AH; Wan J; Spesock A; Sergueeva Z; Shaw BR; Alexander KA
    Nucleic Acids Res; 2006; 34(9):2773-81. PubMed ID: 16717282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of the star strand facilitates assembly of some microRNAs into Ago2-containing silencing complexes in mammals.
    Shin C
    Mol Cells; 2008 Sep; 26(3):308-13. PubMed ID: 18728384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both strands of siRNA have potential to guide posttranscriptional gene silencing in mammalian cells.
    Wei JX; Yang J; Sun JF; Jia LT; Zhang Y; Zhang HZ; Li X; Meng YL; Yao LB; Yang AG
    PLoS One; 2009; 4(4):e5382. PubMed ID: 19401777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argonaute2 is the catalytic engine of mammalian RNAi.
    Liu J; Carmell MA; Rivas FV; Marsden CG; Thomson JM; Song JJ; Hammond SM; Joshua-Tor L; Hannon GJ
    Science; 2004 Sep; 305(5689):1437-41. PubMed ID: 15284456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of asymmetric terminal structures of short RNA duplexes on the RNA interference activity and strand selection.
    Sano M; Sierant M; Miyagishi M; Nakanishi M; Takagi Y; Sutou S
    Nucleic Acids Res; 2008 Oct; 36(18):5812-21. PubMed ID: 18782830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purified Argonaute2 and an siRNA form recombinant human RISC.
    Rivas FV; Tolia NH; Song JJ; Aragon JP; Liu J; Hannon GJ; Joshua-Tor L
    Nat Struct Mol Biol; 2005 Apr; 12(4):340-9. PubMed ID: 15800637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the Binding Interactions between Chemically Modified siRNAs and Human Argonaute 2 Using Microsecond Molecular Dynamics Simulations.
    Harikrishna S; Pradeepkumar PI
    J Chem Inf Model; 2017 Apr; 57(4):883-896. PubMed ID: 28287733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amide-Modified RNA: Using Protein Backbone to Modulate Function of Short Interfering RNAs.
    Kotikam V; Rozners E
    Acc Chem Res; 2020 Sep; 53(9):1782-1790. PubMed ID: 32658452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-silencing properties of siRNAs that contain internal amide-bond linkages.
    Gong W; Desaulniers JP
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6934-7. PubMed ID: 23062704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3'-ends of siRNAs.
    Hamada M; Ohtsuka T; Kawaida R; Koizumi M; Morita K; Furukawa H; Imanishi T; Miyagishi M; Taira K
    Antisense Nucleic Acid Drug Dev; 2002 Oct; 12(5):301-9. PubMed ID: 12477280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing.
    Gregory RI; Chendrimada TP; Cooch N; Shiekhattar R
    Cell; 2005 Nov; 123(4):631-40. PubMed ID: 16271387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The design, preparation, and evaluation of asymmetric small interfering RNA for specific gene silencing in mammalian cells.
    Chang C; Hong SW; Dua P; Kim S; Lee DK
    Methods Mol Biol; 2013; 942():135-52. PubMed ID: 23027049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative Quantification of siRNA Strand Loading into Ago2 for Design of Highly Active siRNAs.
    Angart PA; Adu-Berchie K; Carlson RJ; Vocelle DB; Chan C; Walton SP
    Methods Mol Biol; 2019; 1974():41-56. PubMed ID: 31098994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.